Uncategorized
Merck partner reveals bispecific data; Biogen pays $100M for antibody rights
Merck partner reveals bispecific data; Biogen pays $100M for antibody rights
Merck partner reveals first human data for PD-1xVEGF bispecific: Sino Biopharm revealed that six of 11 lung cancer patients responded to a low dose of the drug, known as MK-2010, while four of nine patients … Read More